Saladax Biomedical Raises $8.4 Million
Saladax Biomedical, a Bethlehem, Penn.-based developer of diagnostic tests for the delivery of personalized medicine, has raised $8.4 million in Series C funding. Excel Venture Management led the round, and was joined by return backers Golden Seeds LLC, Ben Franklin Technology Partners and the Life Sciences Greenhouse of Central Pennsylvania. The company previously raised $11.5 million.
5 March 2010•3 mins read
